Pretreatment eosinophil counts as a predictive biomarker in non ‐small cell lung cancer patients treated with immune checkpoint inhibitors

ConclusionOS was significantly longer in ICI-treated NSCLC patients with a pretreatment eosinophil count of 100  ≤ Eo<500 than in the other patients and, thus, has potential as a new predictive biomarker.

Source: Thoracic Cancer - September 6, 2023 Category: Cancer & Oncology Authors: Eiji Takeuchi, Kensuke Kondo, Yoshio Okano, Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Hirokazu Ogino, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka Tags: ORIGINAL ARTICLE Source Type: research